Found: 10
Select item for more details and to access through your institution.
Yellowish nail pigmentation caused by sunitinib.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Durable complete response after stereotactic body radiation therapy in immunotherapy-resistant non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 3, p. 868, doi. 10.4103/jcrt.JCRT_954_20
- By:
- Publication type:
- Article
Durable complete response after stereotactic body radiation therapy in immunotherapy-resistant non-small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- letter
Long-term survival of a patient with programmed death ligand 1-negative lung adenocarcinoma and oligoprogressive disease treated with nivolumab and stereotactic body radiation therapy.
- Published in:
- 2020
- By:
- Publication type:
- case study
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148921
- By:
- Publication type:
- Article
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 3, p. 551, doi. 10.1007/s10549-024-07324-8
- By:
- Publication type:
- Article
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- Report
A Pilot, Phase II, Randomized, Open‐Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab‐Paclitaxel to That of Solvent‐Based Paclitaxel as the First‐Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2‐Negative Metastatic Breast Cancer
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1024, doi. 10.1634/theoncologist.2017-0664
- By:
- Publication type:
- Article
Cáncer de mama y COVID-19: cómo podemos adaptarnos a la pandemia y no poner en riesgo a nuestras pacientes.
- Published in:
- Cancer & Chemotherapy Reviews, 2020, v. 15, n. 1, p. 6
- By:
- Publication type:
- Article
New Forms of Administration of Herceptin®.
- Published in:
- Cancer & Chemotherapy Reviews, 2015, v. 10, n. 2, p. 53
- By:
- Publication type:
- Article